Gapping up
In reaction to strong earnings/guidance: AVAV +4.3%, AA +2.7%, SYRG +1.4%, GTIV +1.1%.
M&A news: RAI +1.9% (IFA Mag report discusses potential British American Tobacco (BTI) buyout).
Select Air carrier related names showing strength after strong AAL op guidance: UAL +2.6%, ALK +2.6%, DAL +2.5%, LUV +2.4%, JBLU +2%.
Other news: LXRX +12.1% ( announced that JDRF will provide funding to support a Phase 2 clinical trial to evaluate the efficacy and safety of LX4211), USU +7.8% (cont vol), ARWR +7.2% (following CNBC Fast Money commentary), CAMT +6.1% (extending Monday's move higher), AAL +5.3% (June RPM +1%; sees Q2 PRASM +5.5-6.5%, adj. pre-tax margin ~12-13%), SDRL +4.7% (cancels contemplated convertible bond issuance and voluntary incentive payment offer ), TXMD +4.6% (following 32%+ move higher yesterday), RVLT +4.6% (still checking), KNDI +3.4% (name may be getting boost from FT story indicating Japan carmaker fuel cell growth), LJPC +2.7% (announces planned initiation of Phase 3 Registration Program for LJPC-501 in resistant hypotension),GWPH +2.3% (still checking), BLUE +2.1% (prices 3 mln shares of common stock at $34.00 per share), TSL +2.1% (announces supply of 200MW PV modules to Zonergy), NQ +1.9% (still checking), AMX +1.3% (confirmed that it resolved to authorize measures to reduce its national market share), BA +1.1% (Co and Emirates finalize order for 150 777Xs).
Analyst comments: JD +3.3% (initiated with a Outperform at Oppenheimer), AINV +1.6% (upgraded to Buy from Neutral at Sun Trust Rbsn Humphrey), KKR +1.6% (upgraded to Outperform from Neutral at Credit Suisse), BIIB +1.4% (target raised to $375 at RBC Capital Mkts ), HFC +1.2% (upgraded to Outperform from Market Perform at Wells Fargo), DB +1.1% (upgraded to Overweight from Neutral at JP Morgan), BRCM +1% (upgraded to Outperform from Perform at Oppenheimer), SLB +0.7% (upgraded to Overweight from Neutral at HSBC Securities), FFIV +0.6% (initiated with a Buy at DA Davidson)
M&A news: RAI +1.9% (IFA Mag report discusses potential British American Tobacco (BTI) buyout).
Select Air carrier related names showing strength after strong AAL op guidance: UAL +2.6%, ALK +2.6%, DAL +2.5%, LUV +2.4%, JBLU +2%.
Other news: LXRX +12.1% ( announced that JDRF will provide funding to support a Phase 2 clinical trial to evaluate the efficacy and safety of LX4211), USU +7.8% (cont vol), ARWR +7.2% (following CNBC Fast Money commentary), CAMT +6.1% (extending Monday's move higher), AAL +5.3% (June RPM +1%; sees Q2 PRASM +5.5-6.5%, adj. pre-tax margin ~12-13%), SDRL +4.7% (cancels contemplated convertible bond issuance and voluntary incentive payment offer ), TXMD +4.6% (following 32%+ move higher yesterday), RVLT +4.6% (still checking), KNDI +3.4% (name may be getting boost from FT story indicating Japan carmaker fuel cell growth), LJPC +2.7% (announces planned initiation of Phase 3 Registration Program for LJPC-501 in resistant hypotension),GWPH +2.3% (still checking), BLUE +2.1% (prices 3 mln shares of common stock at $34.00 per share), TSL +2.1% (announces supply of 200MW PV modules to Zonergy), NQ +1.9% (still checking), AMX +1.3% (confirmed that it resolved to authorize measures to reduce its national market share), BA +1.1% (Co and Emirates finalize order for 150 777Xs).
Analyst comments: JD +3.3% (initiated with a Outperform at Oppenheimer), AINV +1.6% (upgraded to Buy from Neutral at Sun Trust Rbsn Humphrey), KKR +1.6% (upgraded to Outperform from Neutral at Credit Suisse), BIIB +1.4% (target raised to $375 at RBC Capital Mkts ), HFC +1.2% (upgraded to Outperform from Market Perform at Wells Fargo), DB +1.1% (upgraded to Overweight from Neutral at JP Morgan), BRCM +1% (upgraded to Outperform from Perform at Oppenheimer), SLB +0.7% (upgraded to Overweight from Neutral at HSBC Securities), FFIV +0.6% (initiated with a Buy at DA Davidson)